Last updated on November 2017

OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder. Clinical trial NCT01945489.


Brief description of study

OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder. Clinical trial NCT01945489.

Detailed Study Description

This is a study to evaluate the efficacy and safety of onabotulinumtoxinA (BOTOX®) compared with placebo, in achieving a 100% reduction in urinary incontinence in patients with overactive bladder (OAB) not properly managed with an anticholinergic.

Clinical Study Identifier: TX81761

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Cheryl Zinar, RN, BSN

Urologic Consultants of Southeastern Pennsylvania
Bala Cynwyd, PA USA
  Connect »